Phase IIIb study of durvalumab plus platinumeetoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Safety results

被引：3

作者：

Casado, M. D. Isla ^{[1
]}

Arriola, E. ^{[2
]}

Garcia-Campelo, M. R. ^{[3
]}

Tain, P. Diz ^{[4
]}

Blanco, C. Marti ^{[5
]}

Piqueras, M. M. Lopez-Brea ^{[6
]}

Vega, A. L. Moreno ^{[7
]}

Mateos, L. A. Leon ^{[8
]}

Rodriguez, J. M. Oramas ^{[9
]}

Calderon, V. Gutierrez ^{[10
]}

Majem, M. ^{[11
]}

Hernandez, A. Sanchez ^{[12
]}

Aguado, C. ^{[13
]}

Cabellos, R. Alvarez ^{[14
]}

Ciriquian, J. L. Marti ^{[15
]}

Paul, A. Moreno ^{[16
]}

Perez, J. L. Firvida ^{[17
]}

Mellen, A. Callejo ^{[18
]}

Baez, L. ^{[18
]}

Paz-Ares, L. ^{[19
]}

机构：

[1] Hosp Clin Univ Lozano Blesa, Med Oncol Dept, Zaragoza, Spain

[2] Hosp Mar, Dept Med Oncol, Parc Salut Mar, Barcelona, Spain

[3] CHUAC Complexo Hosp Univ A Coruna, Dept Med Oncol, La Coruna, Spain

[4] Hosp Leon, Complejo Asistencial Univ Leon, Dept Med Oncol, Leon, Spain

[5] Hosp Univ Sant Joan Reus, Med Oncol, Reus, Spain

[6] HUMV Hosp Univ Marques Valdecilla, Med oncol, Santander, Spain

[7] Hosp Univ Virgen Rocio, Dept Med Oncol, Seville, Spain

[8] CHUS Complejo Hosp Univ Santiago de Compostela, Med Oncol, Santiago De Compostela, Spain

[9] Hosp Univ Canarias, Med Oncol, Santa Cruz De Tenerife, Canary Islands, Spain

[10] Hosp Reg Univ Malaga Carlos Haya, Med oncol, Malaga, Spain

[11] Hosp Santa Creu & Sant Pau, Med Oncol, Barcelona, Spain

[12] Consorcio Hosp Prov Castellon, Dept Med Oncol, Castellon De La Plana, Spain

[13] Hosp Clin Univ San Carlos, Med Oncol Dept, Madrid, Spain

[14] Hosp Virgen Salud, Oncol Med, Toledo, Spain

[15] Hosp Gen Univ Alicante, Med Oncol, Alicante, Spain

[16] Hosp Galdakao Usansolo, Med Oncol, Galdakao, Spain

[17] Ctr Med El Carmen, Med Oncol, Orense, Spain

[18] AstraZeneca Farmaceut Spain S A, Med Dept, Madrid, Spain

[19] Hosp Univ 12 Octubre, Med Oncol Dept, Edificio Matern 2a planta, Madrid, Spain

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1224

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1993P

引用

页码：S1063 / S1063

页数：1

共 50 条

[21] Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options
Zugazagoitia, Jon
Paz-Ares, Luis
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06) : 671 - +
[22] Anlotinib Plus Etoposide and Carboplatin as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: A Single Arm Phase II Trial
Han, B.
Zhang, W.
Zhang, B.
Chen, Y.
Zhang, Y.
Lou, Y.
Dong, Y.
Qian, F.
Zhou, W.
Yang, Z.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S503 - S503
[23] Phase II Study of Pembrolizumab, Plinabulin plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer
Huang, Y.
Tong, F.
Zhang, R.
Liu, P.
Dong, X.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S704 - S705
[24] Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USA
Yelena Ionova
Wilson Vuong
Omar Sandoval
Jodie Fong
Vincent Vu
Lixian Zhong
Leslie Wilson
Clinical Drug Investigation, 2022, 42 : 491 - 500
[25] Cost-effectiveness of adding durvalumab to first-line chemotherapy for extensive-stage small-cell lung cancer in China
Liu, Guoqiang
Kang, Shuo
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (01) : 85 - 91
[26] Cost-effectiveness analysis of durvalumab, tremelimumab, and etoposide-platinum in first-line treatment of extensive-stage small cell lung cancer
Meng, Mingyu
Liu, Xiaoxia
Liang, Xueyan
Chen, Xiaoyu
Li, Yan
MEDICINE, 2024, 103 (16) : E37836
[27] Phase II study of durvalumab plus olaparib as maintenance therapy in extensive-stage small-cell lung cancer (TRIDENT): Preliminary efficacy and safety results
Huang, Yan
Jia, Jun
Wang, Qiming
Liu, Xianling
Zhang, Li
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[28] Phase II study of irinotecan and carboplatin followed by maintenance sunitinib in the first-line treatment of extensive-stage small cell lung cancer
Lubiner, E. T.
Spigel, D. R.
Greco, F. A.
Rubin, M. S.
Shipley, D.
Thompson, D. S.
Eakle, J. F.
Brown, R. H.
Burris, H. A., III
Hainsworth, J. D.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[29] A comparative study on etoposide combined with lobaplatin or cisplatin in the first-line treatment of extensive-stage small cell lung cancer
Li, Shujun
Liang, Yahai
Wu, Yanxia
Huang, Zhong
Lin, Yanming
Yang, Zhixiong
Chen, Hualin
Wu, Aibing
JOURNAL OF BUON, 2020, 25 (03): : 1490 - 1496
[30] Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USA
Ionova, Yelena
Vuong, Wilson
Sandoval, Omar
Fong, Jodie
Vu, Vincent
Zhong, Lixian
Wilson, Leslie
CLINICAL DRUG INVESTIGATION, 2022, 42 (06) : 491 - 500

← 1 2 3 4 5 →